Immuno-Biological Laboratories Co., Ltd.

Founded in 1982, Immuno-Biological Laboratories Co., Ltd (IBL) provides ISO 13485-certified solutions for pharmaceutical companies, diagnostic manufacturers, universities, hospitals, and biomedical research institutes.  With a strong focus on antibody development and disease biomarker research—particularly in aging, neurodegenerative diseases (such as Alzheimer’s), inflammatory conditions, kidney diseases, and metabolic disorders, and a large portfolio including  ELISA assay kits, monoclonal and polyclonal antibodies, customized antibody development services, and specialized immunological research reagents,  IBL is committed to providing the best solutions for enabling sufferers of intractable diseases around the world to enjoy happy and healthy lives.  

Cambridge Bioscience is pleased to provide IBL products in the UK and Ireland.